Prostate cancer is one of the most common cancers among men. Early detection of prostate cancer prevents malignancy and leads to a nearly 100% survival rate whereas late diagnosis reduces it to ~28%. Currently, the gold standard for testing prostate cancer is measuring the prostate-specific...
Although CRISPR technology is well-known for its ability for gene knock-out and therapeutic applications, it has been recently evolved as a powerful technique for diagnostics purposes. The strength of CRISPR diagnostics methods along with the superiority of microfluidics in manufacturing point-of-care (POC) diagnostics chips creates...
microRNA abbreviated as miRNA is a non-coding RNA. Non-coding RNAs do not translate into proteins and are mainly responsible for regulatory affairs in the cells. The “micro” prefix stems from their short length. The miRNAs normally span from 18 to 28 nucleotides. So, miRNA is...
After the successful design and testing of many types of organ-on-a-chips such as heart on a chip, kidney on a chip, lung on a chip, etc., the Wyss Institute has now unveiled a colon on a chip hoping to gain a better understanding of the...
As reported by leukemia and lymphoma society of Canada, from 2003 to 2012, there has been a 1.4% a year reduction in the mortality rate of leukemia due to the progress in research and treatment methods. Long-term monitoring of leukemia is arduous since it requires...